-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on BrightSpring Health, Raises Price Target to $71

Benzinga·06/02/2026 15:13:11
Listen to the news
Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $62 to $71.